Skip to main content
. 2017 Nov 4;6(10):602–609. doi: 10.1302/2046-3758.610.BJR-2016-0321.R1

Table I.

Age and gender distribution of patients

Group Mean age, yrs (sd) Female, n (%) Male, n (%) Total, n
Non-fracture control 78.8 (4.0) 4 (66.7) 2 (33.3) 6
Fracture control 82.9 (7.8) 8 (57.1) 6 (42.9) 14
Bisphosphonate therapy 77.3 (8.0) 7 (70.0) 3 (30.0) 10